What is Zimigut 200 used for?
Zimigut 200 Tablet is an antibiotic. It is used to treat infectious diarrhea and irritable bowel syndrome with diarrhea (IBS-D) in adults.
Is Zimigut an antibiotic?
Zimigut 400 Tablet is an antibiotic. It works by killing the ammonia-producing bacteria in the digestive tract. This treats your infection and relieves symptoms of hepatic encephalopathy (agitation, confusion, muscle problems). This also helps reduce the recurrence of episodes of hepatic encephalopathy.
Why is Rifagut prescribed?
Rifagut 400 Tablet 10’s belongs to the group of medicines called ‘antibiotics’ or ‘antibacterials’ used to treat infectious traveller’s diarrhoea (in adults and children above 12 years of age) caused by E coli bacteria, hepatic encephalopathy (decreased brain function due to liver disease) and irritable bowel syndrome …
Is Rifagut 200 An antibiotic?
A: Yes, Rifagut 200 is an antibiotic medicine. It is used for the treatment of infectious diarrhea and hepatic encephalopathy.
What is Eldicet used for?
This Eldicet Tablet 6’s is used to treat symptoms of irritable bowel syndrome, including irregular bowels (e.g., constipation or diarrhea), stomach pain, and bloating. It is also used for symptoms associated with other intestinal diseases (involving the bile duct and gallbladder).
What is Sibofix used for?
Sibofix 400 MG Tablet is an effective medicine used to treat bacterial infections of the intestine. It is used for the treatment of traveler’s diarrhea, irritable bowel syndrome with diarrhea caused due to certain specific strains of bacteria.
Is it safe to take Rifagut?
Rifagut 400 Tablet reduces the risk of overt hepatic encephalopathy (HE) recurrence in patients with liver disease. It may cause reddish discoloration of urine. This is normal and harmless. Stop taking Rifagut 400 Tablet and inform your doctor if you have severe diarrhea during or after using Rifagut 400 Tablet.
Is Rifagut a safe antibiotic?
Rifaximin is a broad-spectrum nonabsorbed rifamycin antibiotic with an excellent safety profile, a lack of drug interactions, and minimal effect on the intestinal microbiome. This gut-selective antimicrobial is currently approved for the treatment of travelers’ diarrhea caused with noninvasive E.
